A comprehensive look at the role of hyperlipidemia in promoting colorectal cancer liver metastasis
Citations Over Time
Abstract
Colorectal cancer (CRC) is one of the most malignant cancers, and it tends to migrate to the liver and has a high mortality rate. Several mechanisms behind the metastasis of CRC have been identified, including hyperlipidemia. For example, hyperlipidemia can lead to enhanced stemness and neutrophil infiltration, which increases CRC metastasis. There are three primary aspects to the relationship between hyperlipidemia and CRC metastasis: hyperlipidemia (1) promotes the initial metastatic properties of CRC, (2) stimulates CRC cells to leave the vasculature, and (3) facilitates the development of CRC metastasis. In this study, we provide a comprehensive overview of the role that hyperlipidemia played in CRC metastasis to help reduce the mortality associated with CRC metastasis from the standpoint of metabolic. We also review cancer metastasis.
Related Papers
- → Comparison of plasma lipoprotein profiles and malondialdehyde between hyperlipidemia dogs with/without treatment(2014)12 cited
- Study on risk factors of hyperlipidemia(2000)
- Clinical significance analysis of peripheral blood levels of soluble CD147 detection for patients with hyperlipidemia(2013)
- → Investigation on knowledge of hyperlipidemia in healthy people undergoing medical examination(2010)